The treatment of cervical dystonia with botulinum toxins
- 12 November 2007
- journal article
- review article
- Published by Springer Science and Business Media LLC in Journal of Neural Transmission
- Vol. 115 (4), 579-583
- https://doi.org/10.1007/s00702-007-0831-4
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Retrospective evaluation of the dose of dysport and BOTOX in the management of cervical dystonia and blepharospasm: The REAL DOSE studyMovement Disorders, 2005
- Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: Results of the first US randomized, double‐blind, placebo‐controlled studyMovement Disorders, 2005
- Clinical comparability of marketed formulations of botulinum toxinMovement Disorders, 2004
- Patients' perception of stopping or continuing treatment of cervical dystonia with botulinum toxin type AMovement Disorders, 2000
- Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A–resistant cervical dystoniaNeurology, 1999
- Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A–responsive cervical dystoniaNeurology, 1999
- Treatment of idiopathic spasmodic torticollis with botulinum toxin a: A double‐blind study on twenty‐three patientsMovement Disorders, 1991
- Idiopathic cervical dystonia: Clinical characteristicsMovement Disorders, 1991
- Controlled trial of botulinum toxin injections in the treatment of spasmodic torticollisNeurology, 1989
- Published by Korean Cancer Association